Kokkonen J O, Kovanen P T
Biochem J. 1987 Jan 15;241(2):583-9. doi: 10.1042/bj2410583.
To study the interaction between low-density lipoprotein (LDL) and granules from rat serosal mast cells in vitro, mast cells were stimulated with the degranulating agent 48/80 to induce exocytosis of the secretory granules. Subsequent incubation of the exocytosed granules with 125I-LDL resulted in binding of the labelled LDL to the granules. When increasing amounts of agent 48/80 were added to mast-cell suspensions, a dose-dependent release of granules was observed and a parallel increase in the amount of 125I-LDL bound to granules resulted. 125I-LDL bound to a single class of high-affinity binding sites on the granules. At saturation, 105 ng of LDL were bound per microgram of granule protein. The lipoprotein binding to mast-cell granules was apolipoprotein(apo)-B + E-specific. Thus 125I-LDL binding to the granules was effectively compared for by LDL (apo-B) or by dimyristoyl phosphatidylcholine vesicles containing apo-E, but not by high-density lipoprotein (HDL3) containing apo-AI as their major protein component. Neutralization by acetylation of the positively charged amino groups of apo-B of LDL or presence of a high ionic strength in the incubation medium prevented LDL from binding to the granules, indicating the presence of ionic interactions between the positively charged amino acids of LDL and negatively charged groups of the granules. It could be demonstrated that LDL bound to the negatively charged heparin proteoglycan of the granules. Thus treatment of granules with heparinase resulted in loss of their ability to bind LDL, and substances known to bind to heparin, such as Toluidine Blue, avidin, lipoprotein lipase, fibronectin and protamine, all effectively competed with LDL for binding to the granules. The results show that LDL is efficiently bound to the heparin proteoglycan component of mast-cell granules once the mast cells are stimulated to release their granules into the extracellular space.
为了在体外研究低密度脂蛋白(LDL)与大鼠浆膜肥大细胞颗粒之间的相互作用,用脱颗粒剂48/80刺激肥大细胞以诱导分泌颗粒的胞吐作用。随后将胞吐的颗粒与125I-LDL一起孵育,导致标记的LDL与颗粒结合。当向肥大细胞悬液中加入越来越多的48/80试剂时,观察到颗粒呈剂量依赖性释放,并且与颗粒结合的125I-LDL量平行增加。125I-LDL与颗粒上一类高亲和力结合位点结合。饱和时,每微克颗粒蛋白结合105 ng的LDL。脂蛋白与肥大细胞颗粒的结合是载脂蛋白(apo)-B + E特异性的。因此,125I-LDL与颗粒的结合可被LDL(apo-B)或含有apo-E的二肉豆蔻酰磷脂酰胆碱囊泡有效竞争,但不能被以apo-AI作为主要蛋白质成分的高密度脂蛋白(HDL3)竞争。LDL的apo-B带正电荷的氨基乙酰化中和或孵育介质中高离子强度的存在可阻止LDL与颗粒结合,表明LDL带正电荷的氨基酸与颗粒带负电荷的基团之间存在离子相互作用。可以证明LDL与颗粒带负电荷的肝素蛋白聚糖结合。因此,用肝素酶处理颗粒会导致其结合LDL的能力丧失,并且已知与肝素结合的物质,如甲苯胺蓝、抗生物素蛋白、脂蛋白脂肪酶、纤连蛋白和鱼精蛋白,都能有效地与LDL竞争结合颗粒。结果表明,一旦肥大细胞被刺激将其颗粒释放到细胞外空间,LDL就能有效地与肥大细胞颗粒的肝素蛋白聚糖成分结合。